$CPIX
CUMBERLAND PHARMACEUTICALS INC

2022 Q4 Form 10-Q Financial Statement

#000162828022029906 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $9.124M $11.41M
YoY Change 9.66% 41.38%
Cost Of Revenue $4.450M $2.224M
YoY Change 99.99% 67.5%
Gross Profit $4.673M $9.189M
YoY Change -23.32% 36.24%
Gross Profit Margin 51.22% 80.51%
Selling, General & Admin $6.887M $6.277M
YoY Change 2.51% 7.47%
% of Gross Profit 147.37% 68.31%
Research & Development $1.406M $1.714M
YoY Change -12.83% 17.91%
% of Gross Profit 30.08% 18.66%
Depreciation & Amortization $511.5K $1.545M
YoY Change -52.51% 43.86%
% of Gross Profit 10.94% 16.81%
Operating Expenses $8.751M $7.991M
YoY Change -6.39% 9.55%
Operating Profit -$2.278M -$288.6K
YoY Change -47.68% -81.54%
Interest Expense -$133.8K $149.3K
YoY Change 535.14% 645.92%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$2.412M -$416.3K
YoY Change -44.88% -73.58%
Income Tax $48.15K $6.900K
% Of Pretax Income
Net Earnings -$2.441M -$408.6K
YoY Change -36.57% -61.28%
Net Earnings / Revenue -26.75% -3.58%
Basic Earnings Per Share -$0.17 -$0.03
Diluted Earnings Per Share -$0.17 -$0.03
COMMON SHARES
Basic Shares Outstanding 14.46M shares 14.66M shares
Diluted Shares Outstanding 14.48M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.76M $19.54M
YoY Change -26.93% -24.38%
Cash & Equivalents $19.76M $19.54M
Short-Term Investments
Other Short-Term Assets $3.085M $3.739M
YoY Change -7.63% 196.95%
Inventory $9.864M $10.65M
Prepaid Expenses
Receivables $13.16M $15.23M
Other Receivables $0.00 $0.00
Total Short-Term Assets $45.87M $49.16M
YoY Change 0.4% 4.12%
LONG-TERM ASSETS
Property, Plant & Equipment $284.0K $490.8K
YoY Change -35.83% -0.54%
Goodwill $914.0K $1.933M
YoY Change 3.63% 119.15%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.521M $2.427M
YoY Change -26.29% -26.5%
Total Long-Term Assets $47.05M $41.62M
YoY Change 21.36% 3.12%
TOTAL ASSETS
Total Short-Term Assets $45.87M $49.16M
Total Long-Term Assets $47.05M $41.62M
Total Assets $92.93M $90.78M
YoY Change 10.02% 3.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.82M $11.51M
YoY Change 12.22% 24.66%
Accrued Expenses $17.59M $229.6K
YoY Change 102.9% -79.02%
Deferred Revenue $614.6K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.58M $25.31M
YoY Change 48.24% 41.02%
LONG-TERM LIABILITIES
Long-Term Debt $16.20M $17.70M
YoY Change 8.0% 18.0%
Other Long-Term Liabilities $7.585M $9.279M
YoY Change 1.28% 16.29%
Total Long-Term Liabilities $7.585M $26.98M
YoY Change 1.28% 17.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.58M $25.31M
Total Long-Term Liabilities $7.585M $26.98M
Total Liabilities $56.95M $52.29M
YoY Change 36.06% 27.76%
SHAREHOLDERS EQUITY
Retained Earnings -$11.21M -$8.768M
YoY Change 98.79% 389.59%
Common Stock $47.47M $47.53M
YoY Change -2.02% -2.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.27M $38.76M
YoY Change
Total Liabilities & Shareholders Equity $92.93M $90.78M
YoY Change 10.02% 3.66%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$2.441M -$408.6K
YoY Change -36.57% -61.28%
Depreciation, Depletion And Amortization $511.5K $1.545M
YoY Change -52.51% 43.86%
Cash From Operating Activities $3.638M $2.635M
YoY Change 85.64% -2683.4%
INVESTING ACTIVITIES
Capital Expenditures $1.641M -$218.6K
YoY Change -2167.5% 101.89%
Acquisitions
YoY Change
Other Investing Activities $1.000M $899.4K
YoY Change 1802.23%
Cash From Investing Activities -$640.8K $680.8K
YoY Change 2291.86% -728.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.781M -1.991M
YoY Change 278.19% -619.86%
NET CHANGE
Cash From Operating Activities 3.638M 2.635M
Cash From Investing Activities -640.8K 680.8K
Cash From Financing Activities -2.781M -1.991M
Net Change In Cash 216.4K 1.325M
YoY Change -81.93% 666.95%
FREE CASH FLOW
Cash From Operating Activities $3.638M $2.635M
Capital Expenditures $1.641M -$218.6K
Free Cash Flow $1.997M $2.854M
YoY Change -2.05% 45635.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001087294
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33637
dei Entity Registrant Name
EntityRegistrantName
Cumberland Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1765329
dei Entity Address Address Line1
EntityAddressAddressLine1
1600 West End Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1300
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
255-0068
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
CPIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14464127 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19541538 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27040816 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15232697 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6877346 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
10647529 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8429882 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3738842 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3339969 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
49160606 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
45688013 usd
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
7497356 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9048567 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
490826 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
442635 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29048043 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23954475 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1932876 usd
CY2021Q4 us-gaap Goodwill
Goodwill
882000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
219850 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13565862 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2426996 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3419908 usd
CY2022Q3 us-gaap Assets
Assets
90776553 usd
CY2021Q4 us-gaap Assets
Assets
84459798 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11510756 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9640980 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229605 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8668303 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25306223 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19278960 usd
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
17700000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2022Q3 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
9279208 usd
CY2021Q4 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
7488844 usd
CY2022Q3 us-gaap Liabilities
Liabilities
52285431 usd
CY2021Q4 us-gaap Liabilities
Liabilities
41857820 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42601978 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90776553 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6672442 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14436583 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14436583 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14742754 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14742754 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
47532375 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
48452906 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8768112 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5638600 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
38764263 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
42814306 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-273141 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-212328 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38491122 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4071638 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84459798 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11413072 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8072540 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32887269 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27665182 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2224443 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1328027 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6468212 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5486005 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4110397 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3800288 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13281511 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11709445 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1714254 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1453873 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5283083 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6367438 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2166118 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2039799 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3169625 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1486448 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1013948 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4609146 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3354080 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
11701660 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
9635935 usd
us-gaap Costs And Expenses
CostsAndExpenses
36314394 usd
us-gaap Costs And Expenses
CostsAndExpenses
30988606 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-288588 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1563395 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3427125 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3323424 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
21602 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7394 usd
us-gaap Profit Loss
ProfitLoss
281459 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
52709 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
19411 usd
CY2022Q3 us-gaap Other Income
OtherIncome
0 usd
CY2021Q3 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
2187140 usd
CY2022Q3 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
CY2021Q3 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
611330 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
149340 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
20021 usd
us-gaap Interest Expense
InterestExpense
406539 usd
us-gaap Interest Expense
InterestExpense
70297 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-416326 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1576022 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1187170 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6900 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7458 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20700 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22375 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-423226 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1583480 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3190325 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
496787 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1491004 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-423226 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 usd
us-gaap Profit Loss
ProfitLoss
-3190325 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14587 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-31415 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-60813 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-58651 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-408639 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1055278 usd
us-gaap Net Income Loss
NetIncomeLoss
-3129512 usd
us-gaap Net Income Loss
NetIncomeLoss
340110 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.21
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.10
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.21
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14477478 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14880887 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14618975 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14939919 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14477478 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14880887 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14618975 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15139904 shares
us-gaap Profit Loss
ProfitLoss
-3190325 usd
us-gaap Profit Loss
ProfitLoss
281459 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1491004 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3190325 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4816630 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3529245 usd
us-gaap Share Based Compensation
ShareBasedCompensation
320598 usd
us-gaap Share Based Compensation
ShareBasedCompensation
517081 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1051908 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-632646 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4815365 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2891759 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7608 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33943 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2187140 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
611330 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8184656 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2527183 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1338881 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2555393 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4355396 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1627350 usd
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
8778631 usd
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-2873596 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2472453 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-943439 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1491004 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4815365 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4382763 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
255676 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94485 usd
cpix Proceeds From Settlement Of Patent Litigation
ProceedsFromSettlementOfPatentLitigation
21757 usd
cpix Proceeds From Settlement Of Patent Litigation
ProceedsFromSettlementOfPatentLitigation
0 usd
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
877597 usd
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
13500000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
177362 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
180613 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13033684 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-475098 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
46700000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
45000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
44000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1117576 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1792573 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
863383 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1025657 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
719041 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2818230 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7499278 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1089435 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27040816 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24753796 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19541538 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25843231 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46873394 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162960 usd
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
303088 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
144661 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
191954 usd
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
484965 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1223491 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47808407 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47808407 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162167 usd
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
237616 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46646265 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42601978 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
159901 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
566043 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1402433 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40793403 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40793403 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-27753 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
196692 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1364666 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39204292 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39204292 usd
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
399600 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
188449 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
78793 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-423226 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38491122 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of contingent consideration liabilities associated with business combinations.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-423226 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1583480 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
496787 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-423226 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14587 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-31415 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-408639 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1055278 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14477478 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14880887 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14477478 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14880887 shares
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3190325 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1491004 usd
us-gaap Profit Loss
ProfitLoss
-3190325 usd
us-gaap Profit Loss
ProfitLoss
281459 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-60813 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-58651 usd
us-gaap Net Income Loss
NetIncomeLoss
-3129512 usd
us-gaap Net Income Loss
NetIncomeLoss
340110 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14618975 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14939919 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
199985 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14618975 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15139904 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
233750 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
158900 shares
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11413072 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8072540 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32887269 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27665182 usd
CY2022Q3 cpix Revenue Recognition Milestone Payments
RevenueRecognitionMilestonePayments
100000 usd
cpix Revenue Recognition Milestone Payments
RevenueRecognitionMilestonePayments
600000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1800000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1400000 usd
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
7500000 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9000000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11738972 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12374983 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12374983 usd
CY2022Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
128168 usd
CY2021Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
164378 usd
CY2021Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
164378 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6277745 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4939088 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4939088 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
18144885 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
17478449 usd
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
7497356 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9048567 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
10647529 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8429882 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0742
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
219850 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229605 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2022Q3 cpix Lease Liability
LeaseLiability
229605 usd
CY2021Q4 cpix Lease Liability
LeaseLiability
1059693 usd
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
200000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
150533 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
92477 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
243010 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13405 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
229605 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
861398 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
910975 usd
us-gaap Sublease Income
SubleaseIncome
424632 usd
us-gaap Sublease Income
SubleaseIncome
526868 usd
CY2017Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
100000000 usd
CY2021Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
19000000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44100000 usd
CY2022Q2 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
600000 usd
CY2019 cpix Financial Consideration Payment Period
FinancialConsiderationPaymentPeriod
P2Y
CY2020 cpix Financial Consideration Number Of Installments
FinancialConsiderationNumberOfInstallments
4 installment
CY2020 cpix Proceeds From Sale Of Intangible Assets Installment Payment
ProceedsFromSaleOfIntangibleAssetsInstallmentPayment
3000000 usd
CY2021 cpix Financial Consideration Number Of Installments
FinancialConsiderationNumberOfInstallments
4 installment
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
496787 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1491004 usd

Files In Submission

Name View Source Status
0001628280-22-029906-index-headers.html Edgar Link pending
0001628280-22-029906-index.html Edgar Link pending
0001628280-22-029906.txt Edgar Link pending
0001628280-22-029906-xbrl.zip Edgar Link pending
a2022q3-exhibit311.htm Edgar Link pending
a2022q3-exhibit312.htm Edgar Link pending
a2022q3-exhibit321.htm Edgar Link pending
cpix-20220930.htm Edgar Link pending
cpix-20220930.xsd Edgar Link pending
cpix-20220930_cal.xml Edgar Link unprocessable
cpix-20220930_def.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_1.jpg Edgar Link pending
image_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pinnaclebank-cpiamend9tolo.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cpix-20220930_lab.xml Edgar Link unprocessable
cpix-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cpix-20220930_htm.xml Edgar Link completed